I believe it has been shown in a few of Meso clinical trials that our therapy works in heathier patients that still have a descent immune system. Our cells call in the curing cells if they are available. Thats why the trials did poorly when we treated the sickest of the sick. They set us up for failure and ended the trial early.
I have not seenmuch talk here about the fda changing approvoals of new drugs based on real world evidence and comparisions to historical trials instead of placebo.
Perhaps a new paradigm might be coming.
I se Biden talking about new therapies being approved in sept oct before midterm ellections
GL my Auzzie friends
MSB 2022 - The road to commercialisation, page-815
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $2.625M | 2.429M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 43901 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 21188 | 5 |
View Market Depth
| Last trade - 12.20pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |